Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12,586,921
-
Total 13F shares
-
10,343,866
-
Share change
-
+391,054
-
Total reported value
-
$155,080,846
-
Price per share
-
$15.00
-
Number of holders
-
42
-
Value change
-
+$6,727,908
-
Number of buys
-
27
-
Number of sells
-
10
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q3 2025
As of 30 Sep 2025,
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,343,866 shares.
The largest 10 holders included
FRED ALGER MANAGEMENT, LLC, FEDERATED HERMES, INC., JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, VANGUARD GROUP INC, Cable Car Capital, LP, SPHERA FUNDS MANAGEMENT LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., and Woodline Partners LP.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.